Tuesday 14 July 2026

United States

ZAGENO Secures $33M Funding to Revolutionize Life Science Research Procurement
26th May, 2023

ZAGENO Secures $33M Funding to Revolutionize Life Science Research Procurement

ZAGENO, the leading online marketplace for life science research products, ...

Panavance Therapeutics to Present at BIO International Convention
25th May, 2023

Panavance Therapeutics to Present at BIO International Convention

Panavance Therapeutics Inc. is a privately-held, clinical-stage pharmaceuti...

Pluton Biosciences Raises $16.5M Series A to Harness Microbes for Climate Change Combat
25th May, 2023

Pluton Biosciences Raises $16.5M Series A to Harness Microbes for Climate Change Combat

Pluton Biosciences, a startup leveraging the power of microbes to create co...

Folia Health Launches Canopy Series: User-Led Research Program
24th May, 2023

Folia Health Launches Canopy Series: User-Led Research Program

Today, Folia Health announced a first-of-its-kind observational research in...

Phathom Pharmaceuticals Resubmits New Drug Application for Erosive GERD to FDA
24th May, 2023

Phathom Pharmaceuticals Resubmits New Drug Application for Erosive GERD to FDA

Phathom Pharmaceuticals, Inc., a biopharmaceutical company focused on devel...

Telesis Bio Announces First Commercial Shipment of BioXp Select DNA Cloning Kit
23rd May, 2023

Telesis Bio Announces First Commercial Shipment of BioXp Select DNA Cloning Kit

Telesis Bio Inc., a leader in automated multi-omic and synthetic biology so...

Mount Sinai Enhances Cancer Care with $4 Million Expansion, Including Infusion Center
22nd May, 2023

Mount Sinai Enhances Cancer Care with $4 Million Expansion, Including Infusion Center

The Mount Sinai Health System today held a grand opening of the expansion o...

Adamis Pharmaceuticals releases Q1 2023 financials and provides corporate update.
16th May, 2023

Adamis Pharmaceuticals releases Q1 2023 financials and provides corporate update.

Adamis Pharmaceuticals Corporation, a commercial-stage biopharmaceutical co...

Brim to launch funding round for late-stage clinical trial & phase 2 trial for orphan drug BRM424 in the US.
10th May, 2023

Brim to launch funding round for late-stage clinical trial & phase 2 trial for orphan drug BRM424 in the US.

BRIM, a clinical-stage biotechnology company focusing on developing regener...

NeuroStar Expands “Tap Into Possibility” Campaign in Honor of Mental Health Awareness Month
10th May, 2023

NeuroStar Expands “Tap Into Possibility” Campaign in Honor of Mental Health Awareness Month

Neuronetics, Inc., a commercial stage medical technology company focused on...